Merrion Pharmaceuticals, LLC Report issue

For profit Phase 2
Founded: Dublin Ireland (2004)
Status: Defunct (2007)

Organization Overview

First Clinical Trial
2007
NCT00471185
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

acyline (2 trials)

zoledronic acid (zometa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2